Gouri: Polycaprolactone Injections and What Is Actually Injected

Someone offered you Gouri: what exactly would be injected?

If a video introduced Gouri as a way to “lift the whole face without filler volume”, start by checking the name. GOURI is an injectable product made by DEXLEVO containing polycaprolactone (PCL), a synthetic biodegradable polymer. The company describes it as a liquid form without conventional microparticles and markets it as a collagen stimulator. It is not a device, a topical serum or interchangeable with every other PCL filler. Administration is a medical injection, not something to try at home.

The phrase “stimulates collagen” does not answer your central question: will you see the particular change you want? Gradual changes to tissue quality, filling a specific fold and surgical lifting are different goals. Some promotional descriptions call Gouri an entire-face solution, but the available instructions describe facial tissue augmentation and correction of moderate to severe facial folds and wrinkles. “Full-face lift” is not an equivalent, clinically proven indication.

How does liquid PCL differ from other injectables?

Hyaluronic acid in some fillers adds fairly immediate volume and, in certain complications, may be broken down by hyaluronidase, an enzyme acting on hyaluronic acid. PCL is not hyaluronic acid; do not assume an unwanted Gouri result can be “dissolved” as quickly. The manufacturer emphasises the spread of its liquid form and subsequent tissue response. But “liquid” does not mean risk-free and cannot guarantee identical distribution in every patient.

There are multiple types of PCL products. Research on fillers containing PCL microspheres cannot establish the effect speed, safety or longevity of Gouri without demonstrating that the formulation and technique are the same. Products containing poly-L-lactic acid (PLLA), calcium hydroxylapatite (CaHA), polynucleotides and hyaluronic acid are also not interchangeable: they have distinct mechanisms, instructions, limitations and complication-management strategies. Compare the exact product against your goal, not the marketing word “biostimulation”.

What do studies of liquid PCL actually show?

A pilot study published in November 2025 involved 30 patients treated with liquid PCL in the midface, with two sessions and six months of follow-up. Its PubMed record describes the class of material as liquid PCL; the full paper, product identity and composition must be checked before treating the findings as evidence specific to the GOURI brand. The authors described improvements in measured outcomes and mainly transient reactions. A small study cannot quantify rare complications or establish a universal protocol, guarantee visible lifting for everyone or demonstrate multi-year durability.

An open-label pilot published on 1 October 2026 studied GOURI itself (21% PCL, 210 mg/mL) for horizontal neck lines in 30 Asian adults after three sessions one month apart and follow-up through six months. Its results are preliminary and there was no randomised control group. A neck study does not authorise use on the neck in your jurisdiction: anatomical indications and injection depth must follow the current local instructions. Measurable changes in such a small study do not exclude rare vascular or delayed inflammatory complications.

Another GOURI-specific paper, published in June 2026, retrospectively described just three women treated around the eyes. The researchers mixed the product with saline and lidocaine for the reported technique. This does not override the prohibitions in the available 2021 instructions against injection around the eyes and mixing with other products. Three cases cannot establish that the technique is safe or transform published clinical experience into an authorised indication. If you are offered periorbital injections or product dilution, first request the current local instructions and verification that the exact approach is permitted; declining a conflicting protocol is reasonable.

Reviews of injectable biostimulators and PCL fillers sometimes report encouraging findings, but formulations, concentrations and injection methods differ. A positive Ellansé study, or a study of another PCL product, is not a Gouri trial. Attractive before-and-after pictures are no substitute for a control group, consistent lighting or long follow-up. The most accurate current summary for Gouri is that early clinical evidence exists, but remains limited in sample size, comparison groups and long-term safety data.

Indications, composition and regulatory status: what to check

The published GOURI instructions DEX-IFU-11, revision 2 of 29 January 2021, specify 210 mg polycaprolactone in a 1 mL prefilled syringe and use for moderate to severe facial folds through implantation in the mid-to-deep dermis. This wording comes from that particular document and does not prove a universal lifting effect. Neither the document nor its indications automatically apply unchanged to every batch or country. DEXLEVO describes its CESABP technology and CE marking in Europe. A marketing statement, a CE mark or authorisation elsewhere does not establish approval for every anatomical site, nor actual availability in Armenia.

The US FDA maintains lists of approved fillers and their precise indications. Do not call Gouri “FDA approved” without an authorisation record for that exact product. Approval of a different PCL device or established medical uses of the polymer do not provide such evidence. The sources reviewed here did not independently verify US authorisation for Gouri, or Armenian registration or actual local provision. If someone offers it to you, request the local regulatory documents, lawful supply-chain information and the instructions for that very package before consenting.

This is especially relevant to promotions for the eye area, forehead, neck, hands or treatment combined with lasers. Do not import a protocol advertised in another country without checking the instructions and obtaining a clinical assessment. The available 2021 instructions specifically prohibit injecting into blood vessels or around the eyes, combining it with laser treatment or chemical peeling, and mixing it with other products. These restrictions concern that edition, not every PCL formulation. The professional should show the full current local instructions, rather than recall a list from memory.

Who should avoid or postpone the procedure?

Never inject into an area with active infection or inflammation. The published 2021 GOURI instructions list people aged 19 or younger, pregnancy, breastfeeding, known PCL hypersensitivity, previous anaphylaxis or severe allergy, bleeding disorders and use of anticoagulants, thrombolytics, certain anti-inflammatory or immunosuppressive medicines among exclusions; several immune conditions and a tendency to abnormal scarring are also listed. It advises avoiding areas with existing permanent implants. The exact exclusions must be checked against the instructions supplied with your current product. Do not discontinue prescribed medication to receive a cosmetic injection: your doctor must weigh bleeding, bruising and the underlying illness.

Pregnancy and breastfeeding are specifically listed as contraindications in the available 2021 GOURI instructions; if planning a pregnancy, discuss postponing an elective treatment in advance. Immune-related illness, systemic treatment or previous complications from fillers require individual assessment. Tell the clinician what has already been injected into your face and when: compatibility cannot be assumed from the term “biostimulator”.

There are also aesthetic reasons not to rush. If you want only hydration, would find a bruise unacceptable or are uncomfortable with the inability to reverse the material quickly, skincare or postponement may be more suitable. With substantial sagging in the lower face, promises that liquid PCL replaces surgery are likely to create unrealistic expectations. A practitioner who acknowledges limits is more trustworthy than one promising equal rejuvenation for every face.

What happens during treatment, and is it painful?

The visit should begin with an examination of your face at rest and in motion, a discussion of how much change you want and a medical history. The practitioner should show genuine packaging, markings, expiry date and instructions. Then discuss the exact area and depth, pain management, likely reaction and follow-up. The procedure uses injection instruments; a web article cannot safely prescribe the technique, number of sites or amount. A suggestion that you buy a product yourself and bring it in is a warning sign.

You may feel a puncture, pressure or burning; intensity varies with technique and personal sensitivity. Even use of a cannula—a flexible, blunt-ended tube—does not eliminate vascular risk. A more useful question than “will it be completely painless?” is how the clinician responds to sudden unusual pain and arranges emergency help. You may pause the procedure before another injection if the explanations are inadequate.

What might you see immediately, in a week and later?

Puncture marks, mild swelling, tenderness, redness and bruises may follow an injection. Sometimes they settle quickly; sometimes they remain visible longer. A few marks might not matter during quiet office work, but one bruise can be conspicuous in close-up photographs. The published 2021 instructions additionally specify no makeup for 12 hours and avoidance of prolonged sunlight or UV exposure and saunas for 2 weeks; confirm the current local instructions and personalised advice. With an important meeting in three days, nobody can promise that every sign will be gone. Leave unpredictable extra time instead of trusting “zero downtime” advertising.

The manufacturer describes gradual collagen stimulation and gives its own time estimates, which are not guaranteed outcomes for individual patients. Distinguish the reduction of early swelling from a later treatment response. Do not schedule additional injections merely because an advertising photo shows earlier change. The duration of Gouri's specific effect is not well established by independent, long-term comparative trials.

Complications: a clear plan without alarmism

As with other injectable implants, bruising, swelling, tenderness, infection, lumps and inflammatory nodules are possible. For dermal fillers as a category, regulators describe rare but serious blood-vessel complications: material entering or blocking a vessel can injure skin and may cause blindness or stroke. Those general warnings do not quantify the frequency of these events with Gouri itself. They explain why a liquid formula and fewer injection points do not mean zero risk.

Sudden severe or worsening pain, blanching or an unusual net-like skin colour, worsening eyesight, double vision, a sudden severe headache, weakness or speech difficulty after injection require emergency medical care immediately. Do not wait overnight or massage the area yourself when a vascular event is suspected. Fever, spreading redness or an increasingly hot, painful lump warrants urgent medical assessment for possible infection or marked inflammation.

Gouri is not hyaluronic acid, so routine enzymatic dissolution with hyaluronidase should not be expected to work. A plan for unwanted effects and complications must exist before injection. Social media reviews rarely reveal rare events and may not show what happened months later. There is no need to panic, but choose an experienced injector trained in facial vascular anatomy who explains limitations and has a route to emergency treatment.

How does Gouri compare with Profhilo, Radiesse and hyaluronic acid fillers?

When brand names sit side by side on a menu, it may seem like choosing the most “natural” one. Profhilo uses hyaluronic-acid technology; Radiesse contains calcium hydroxylapatite; conventional HA fillers may address specific volume needs; and Gouri is a liquid PCL product. They have different target tissues, authorised zones, contraindications, evidence bases and approaches to managing complications. Two products promoted for a “fresher face” are not necessarily real substitutes.

Start any comparison with anatomy: is the need for volume, superficial skin quality, treatment of inflammation or simply comfort? Next check exact local authorisation and instructions, research for that body area and people with similar characteristics, ability to reverse effects, full-course costs and visible recovery. Do not choose PCL as “best” from one photograph or because it sounds newer. Some goals do not require injections at all.

What documents and answers do you need before consenting?

• Show me the full GOURI product name, DEXLEVO manufacturer, factory packaging, batch number, expiry date and local instructions for this version.
• Is registration confirmed for this country and this anatomical area? Who may legally perform the procedure?
• Which studies examine Gouri liquid PCL itself rather than a different PCL filler? Which are small pilots and which are robust comparisons?
• What would a realistic change look like on my unfiltered face, and how would we assess it after swelling subsides?
• How do my medical conditions, medicines, prior fillers and pregnancy plans influence this decision?
• Who would manage a vascular injury, infection or nodule, including at weekends? What cannot be dissolved quickly?
• When might punctures and bruises show, what are the care and event restrictions, and can I postpone?

If documents are withheld, you are rushed into paying or told complications “never happen”, declining is safer than accepting a promise of invisible rejuvenation. Gouri should be discussed as a particular injectable with specific instructions and a still-limited clinical evidence base. The important question is not how modern “biostimulation” sounds but whether the likely change, alternatives, risks and the prospect of living with the result fit your priorities.